(A) Immunoblot analysis of MOLT4 cells treated with the ZNL-02-096, ZNL-02-178, AZD1775, or pomalidomide for 24 hrs. (B) MOLT4 cells treated with ZNL-02-096, ZNL-02-178, or AZD1775 for the indicated time points and stained with propidium iodide. Reported as mean ± SEM for n=3 biological replicates; (C) Parental or CRBN−/− MOLT4 cells treated with ZNL-02-096, ZNL-02-178, AZD1775, or Lenalidomide for 24 hrs and stained with propidium iodide. Reported as mean ± SEM for n=3 biological replicates.